pyridine has been researched along with Cystic Fibrosis in 1 studies
azine : An organonitrogen compound of general structure RCH=N-N=CHR or RR'C=N-N=CRR'.
Cystic Fibrosis: An autosomal recessive genetic disease of the EXOCRINE GLANDS. It is caused by mutations in the gene encoding the CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR expressed in several organs including the LUNG, the PANCREAS, the BILIARY SYSTEM, and the SWEAT GLANDS. Cystic fibrosis is characterized by epithelial secretory dysfunction associated with ductal obstruction resulting in AIRWAY OBSTRUCTION; chronic RESPIRATORY INFECTIONS; PANCREATIC INSUFFICIENCY; maldigestion; salt depletion; and HEAT PROSTRATION.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bourget, P | 1 |
| Amin, A | 1 |
| Dupont, C | 1 |
| Abely, M | 1 |
| Desmazes-Dufeu, N | 1 |
| Dubus, JC | 1 |
| Jouani, BL | 1 |
| Merlette, C | 1 |
| Nové-Josserand, R | 1 |
| Pages, J | 1 |
| Panzo, R | 1 |
| Vidal, F | 1 |
| Voge, F | 1 |
| Hubert, D | 1 |
1 other study available for pyridine and Cystic Fibrosis
| Article | Year |
|---|---|
How to minimize toxic exposure to pyridine during continuous infusion of ceftazidime in patients with cystic fibrosis?
Topics: Anti-Bacterial Agents; Ceftazidime; Cystic Fibrosis; Humans; Infusions, Intravenous; Kinetics; Pyrid | 2014 |